Chronic Rhinosinusitis: Are You Diagnosing and Treating Your Patients Correctly?

Name: Chronic Rhinosinusitis Online CME
Brand: AAFP

Free Online CME

Chronic Rhinosinusitis: Are You Diagnosing and Treating Your Patients Correctly? education on multiple screens

Review effective treatment strategies for chronic rhinosinusitis (CRS) in this new three-part on-demand series.

These short-burst videos (about 45 to 50 minutes each) will cover the latest research around the diagnosis, treatment and management of CRS with and without nasal polyps, with an emphasis on the latest evidence-based information on diagnostic tools and treatments.

This on-demand activity is free.

Faculty

Course Director

Justin Bailey, MD
Director of the Procedures Institute and Director of Research and Scholarship for Full Circle Health in Boise, Idaho.

Faculty

Joseph K, Han, MD, FARS, FAAAAI
Professor, Vice Chair of Clinical Affairs and Administration; Chief, Division of Allergy Department of Otolaryngology & Head and Neck Surgery Eastern Virginia Medical School

Anju T. Peters, MD, MSCI
Professor of Medicine Division of Allergy and Immunology; Director, Center for Clinical Research Northwestern University Clinical and Translational Sciences Institute (NUCATS)

Bradford Woodworth, MD, FACS
Professor of Otolaryngology at the University of Alabama at Birmingham.

Learning Objectives

At the end of this activity, you will be able to:

An overview of chronic rhinosinusitis
- Describe the prevalence and epidemiological patterns of chronic rhinosinusitis (CRS) in various populations.
- Assess the significant impact of CRS on patients' quality of life, including physical, emotional, and social aspects.
- Explain the pathophysiology of CRS as a chronic inflammatory condition and distinguish it from infectious sinusitis.
- Apply evidence-based management strategies for CRS, focusing on long-term treatment plans that address the chronic inflammatory nature of the condition.
Advancing diagnostic and treatment strategies for chronic rhinosinusitis
- Differentiate between Chronic Rhinosinusitis (CRS) with nasal polyps (CRSwNP) and without nasal polyps (CRSsNP), and distinguish these from allergic rhinitis.
- Utilize the latest diagnostic tools and techniques for the accurate diagnosis of CRS.
- Apply knowledge through case studies to enhance diagnostic accuracy and patient management.
- Integrate new diagnostic strategies into clinical practice to improve patient outcomes.
The latest evidence for the treatment of patients with chronic rhinosinusitis
- Analyze the latest evidence-based treatments for Chronic Rhinosinusitis (CRS) by reviewing current research findings and clinical guidelines.
- Evaluate the clinical and economic consequences of poor CRS management, identifying cost-effective strategies for patient care.
- Determine the appropriate timing for initiating interventions to optimize patient outcomes in CRS management.
- Implement evidence-based practices for the treatment of CRS to improve patient outcomes and reduce healthcare costs.

System Requirements

High-speed broadband connection required for online access.
Latest version of Firefox, Safari, or Chrome on Windows or Macintosh computers or tablets.
Latest version of Adobe Reader.

Funding Statement

This activity is supported by an educational grant from OptiNose. OptiNose has not had input or editorial control over the content of this activity.

CME Credit Statement

An Overview of Chronic Rhinosinusitis:

The AAFP has reviewed An overview of chronic rhinosinusitis and deemed it acceptable for up to .5 Enduring Materials, Self Study AAFP (P/E) credits. Term of Approval is from 1/15/2025 to 1/15/2026. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

AAFP Prescribed credit is accepted by the American Medical Association as equivalent to AMA PRA Category 1 Credits^™toward the AMA Physician's Recognition Award. When applying for the AMA PRA, Prescribed credit earned must be reported as Prescribed credit, not as Category 1.

CME activities approved for AAFP credit are recognized by the AOA as equivalent to AOA Category 2 credit.

Advancing Diagnostic and Treatment Strategies for Chronic Rhinosinusitis:

The AAFP has reviewed Advancing Diagnostic and Treatment Strategies for Chronic Rhinosinusitis and deemed it acceptable for up to .75 Enduring Materials, Self Study AAFP (P/E) credits. Term of Approval is from 2/15/2025 to 1/15/2026. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

AAFP Prescribed credit is accepted by the American Medical Association as equivalent to AMA PRA Category 1 Credist^™ toward the AMA Physician's Recognition Award. When applying for the AMA PRA, Prescribed credit earned must be reported as Prescribed credit, not as Category 1.

CME activities approved for AAFP credit are recognized by the AOA as equivalent to AOA Category 2 credit.

The Latest Evidence for the Treatment of Patients with Chronic Rhinosinusitis:

The AAFP has reviewed The latest evidence for the treatment of patients with chronic rhinosinusitis and deemed it acceptable for up to 1 Enduring Materials, Self Study AAFP (P/E) credits. Term of Approval is from 3/15/2025 to 1/15/2026. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

AAFP Prescribed credit is accepted by the American Medical Association as equivalent to AMA PRA Category 1 Credits^™ toward the AMA Physician's Recognition Award. When applying for the AMA PRA, Prescribed credit earned must be reported as Prescribed credit, not as Category 1.

CME activities approved for AAFP credit are recognized by the AOA as equivalent to AOA Category 2 credit.

Resources You May Also Like

Learn About AAFP

Physician Support

Let Us Help You